Should the FDA Call Out Drug Makers Blocking Generic Competition?
The FDA has published a list of companies that have delayed the development of generic drugs by refusing to provide samples to generic manufacturers. The list includes a number of complaints made against each company by generic manufacturers seeking to make copies, and was released in an effort to "put branded companies on notice," according to the FDA commissioner. Several companies on the list have issued statements denying the claims and stating that the FDA has not sufficiently investigated the supposed access limitations. Are you for or against the FDA publicly naming companies that delay generic drug development?
The FDA published a list of drugmakers that have allegedly delayed the development of generic drugs. Some of the companies adamantly dispute these claims. Are you for or against the FDA publicly naming companies that hinder the creation of generic drugs?

Last Answered: 6 days ago